ArticleDiscover oncology2026

Ligand-receptor pair-based signature score derived from on-treatment tumor specimens predicts immune checkpoint blockade response in metastatic melanoma.

Huancheng Zeng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.